CA
MDT icon

Crewe Advisors’s Medtronic MDT Stock Holding History

Crewe Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41K Buy
523
+129
+33% +$10.4K ﹤0.01% 470
2026
Q1 		$34.2K Buy
394
+90
+30% +$8.62K ﹤0.01% 419
2025
Q4 		$29.2K Buy
304
+48
+19% +$4.66K ﹤0.01% 423
2025
Q3 		$24.4K Sell
256
-17
-6% -$1.56K ﹤0.01% 461
2025
Q2 		$23.8K Sell
273
-25
-8% -$2.12K ﹤0.01% 350
2025
Q1 		$26.8K Buy
298
+51
+21% +$4.56K ﹤0.01% 316
2024
Q4 		$19.7K Sell
247
-1,157
-82% -$100K ﹤0.01% 355
2024
Q3 		$126K Hold
1,404
– – 0.01% 199
2024
Q2 		$111K Sell
1,404
-75
-5% -$6.15K 0.01% 256
2024
Q1 		$129K Buy
+1,479
New +$126K 0.02% 236
2023
Q3 		– Sell
-426
Closed -$37.5K – 790
2023
Q2 		$37.5K Sell
426
-637
-60% -$54.8K 0.01% 294
2023
Q1 		$85.7K Sell
1,063
-376
-26% -$30.6K 0.01% 245
2022
Q4 		$112K Buy
1,439
+73
+5% +$5.92K 0.02% 208
2022
Q3 		$110K Buy
1,366
+169
+14% +$15.2K 0.02% 213
2022
Q2 		$107K Buy
1,197
+737
+160% +$74.7K 0.02% 202
2022
Q1 		$51K Hold
460
– – 0.01% 223
2021
Q4 		$48K Buy
460
+296
+180% +$34.3K 0.01% 189
2021
Q3 		$21K Sell
164
-40
-20% -$5.18K 0.01% 209
2021
Q2 		$25K Sell
204
-65
-24% -$8.16K 0.01% 204
2021
Q1 		$32K Hold
269
– – 0.01% 181
2020
Q4 		$32K Sell
269
-30
-10% -$3.3K 0.01% 168
2020
Q3 		$31K Buy
+299
New +$30K 0.01% 156
2020
Q1 		– Sell
-30
Closed -$3K – 222
2019
Q4 		$3K Buy
+30
New +$3.29K ﹤0.01% 222
2019
Q3 		– Sell
-6
Closed -$1K – 281
2019
Q2 		$1K Hold
6
– – ﹤0.01% 288
2019
Q1 		$1K Buy
+6
New +$537 ﹤0.01% 234

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Crewe Advisors's MDT Position: Q2 2026 in Review

Crewe Advisors increased its Medtronic (MDT) stake by 33% in Q2 2026, buying an estimated $10.4K and bringing the position to 523 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Crewe Advisors first reported a position in MDT in Q1 2019 and has held it in 25 quarters since. The position peaked at $129K in Q1 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Crewe Advisors held 523 shares of Medtronic worth $41K as of Q2 2026.
  • Crewe Advisors bought 129 Medtronic shares in Q2 2026, an estimated $10.4K.
  • Medtronic made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #470 holding.
  • Crewe Advisors first reported a position in Medtronic in Q1 2019 and has held it in 25 quarters since.
  • Crewe Advisors's Medtronic position peaked at $129K in Q1 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.